https://www.selleckchem.com/products/gw2580.html
ery systems.[This retracts the article DOI 10.2147/IJN.S323974.]. Patients with chronic obstructive pulmonary disease (COPD) often have osteoporosis and diabetes as comorbid conditions. Anti-diabetic medication, including metformin, has protective effects on osteoporosis in experimental studies. We therefore studied whether patients with COPD receiving anti-diabetic medication had a lower osteoporosis prevalence in a large COPD cohort, COSYCONET. Assessment of osteoporosis was based on patients' reports of physician-based diagnoses and t